Established in 2010, Gerritsen Consulting has worked with venture capital firms, virtual companies, small start-ups, and small and mid-size biopharma companies in the USA as well as abroad.
- As an independent consultant, Mary can be very flexible, working on site or off site, interfacing with your employees, consultants and partners.
- She has written and or edited 16 IND applications, as well as numerous investigator brochures, clinical protocols (Phase I), scientific reports, SOPs and other materials needed to transition companies from preclinical into Phase I, and can play a leadership role or work with medical writing teams.
- Her breadth of knowledge and years of experience in target identification and assessment can be leveraged to assess new targets, potential collaborations, partnership opportunities and alternative/additional therapeutic indications.
